Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionmvd4fi1kf3id3i8juv6skk557gm871ia): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
This prospective observational pilot study investigated the effect of individualized homeopathy on male infertility based on sperm count, hormone values and general health. Forty-five subfertile men were treated with single homeopathic remedies for an average of 10.3 months. The drugs were prescribed on the basis of the overall symptomatic situation. The variables 'sperm density', 'percentage of sperm with good progressive motility' and 'density of sperm with good propulsive motility' improved significantly, especially in cases of oligoasthenozoospermia. The general health of patients improved significantly. The following factors emerged as positive predictors of therapy success: alcohol consumption below 30 g/day, non-smoking, the presence of less than five dental amalgam fillings, no exposure to noxious substances at the workplace and no previous inflammatory genital diseases. The factors stress, age above 36, high coffee consumption and long duration of unwanted childlessness did not have a negative impact on therapy outcome in this study. The rate of improvement in sperm count through homeopathic therapy is comparable to the improvement achieved by conventional therapy, so that individualized-homeopathic treatment may be considered a useful alternative to conventional treatment of subfertile men. For further investigation, a randomised, therapy-controlled clinical study with parallel group design would be useful (homeopathic therapy vs conventional andrological therapy).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1054/homp.2002.0024 | DOI Listing |
BMC Complement Med Ther
March 2025
Institute of Pharmaceutical Biology, Goethe-University, Frankfurt Am Main, Germany.
Background: Gynecological ailments have a negative impact on quality of life and productivity. Standard treatment is associated with poor tolerability and other issues related to public health and environment. Herbal Medicinal Products (HMPs) are used traditionally for the treatment of menstrual and menopausal ailments as well as uncomplicated urinary tract infections (uUTIs) for centuries and constitute a suitable addition to current treatment options.
View Article and Find Full Text PDFJ Prev Med Hyg
December 2024
Faculty of Pharmacy, Lahore College of Women University, Lahore, Pakistan.
Introduction: Breast cancer is a major worldwide health concern that affects women in both developed and developing nations. The purpose of the study is to assess Pakistani women with breast cancer's present understanding of breast self-examination (BSE) as well as their choices for traditional and non-conventional breast cancer treatment options.
Methods: A cross-sectional study was carried out in two hospitals' cancer departments as well as homeopathic and nutritional clinics in Lahore, Pakistan.
BMC Complement Med Ther
March 2025
All India Institute of Medical Sciences, New Delhi, 110029, India.
Background: Hypertension presents as a modifiable risk factor for cardiovascular diseases, with approximately two-thirds of the global hypertensive population concentrated in low- and middle-income nations. Sarpagandha Mishran is an Ayurveda intervention utilized for the management of hypertension. The objective of the study is to assess the clinical efficacy and safety of Sarpgandha Mishran in the Management of Stage-I Hypertension.
View Article and Find Full Text PDFVet Sci
February 2025
Department of Animal Science, College of Animal Science and Food Engineering, University of São Paulo, Pirassununga 13635-900, SP, Brazil.
This study aimed to evaluate the effects of an ultra-diluted complex on the health status, growth performance, and blood parameters of dairy calves during the preweaning phase in a double-blind, placebo-controlled trial. During a 75-period trial, thirty-four Holstein newborn calves at the second day of life were completely randomized individually into two treatments: (1) control (CON), oral saline supplementation (5 mL/d); and (2) oral supplementation with 5 mL/d of a ultra-diluted complex (UD): Sulfur: 1060 + Viola tricolor: 1014 + Caladium seguinum: 1030 + Zincum oxydatum: 1030 + Phosphorus: 1060 + Cardus marianus: 1060 + Colibacillinum: 1030 + Podophyllum: 1030 + Vehicle: alcohol. Free access to water and a starter was ensured during the trial period.
View Article and Find Full Text PDFHomeopathy
February 2025
Chief Medical Officer, Nehru Homoeopathic Medical College & Hospital, New Delhi, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!